drugset / Trial / NCT04551924
A Trial of HR18034 in Inguinal Hernia Repair
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Phase I, randomized, double-blind, comparator-controlled study to assess the safety, PK, and efficacy of single postsurgical application of HR18034 compared with Naropin®
Timeline
- Start
- 2020-10-01
- Primary completion
- 2021-05-30
- Completion
- 2021-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR18034 | Unknown | — | — |
| Comparator | Ropivacaine | Other / unclassified | 150 mg | Other |
Indications
No indication recorded.